Surveillance of tuberculosis in Europe

被引:100
|
作者
Rieder, HL
Watson, JM
Raviglione, MC
Forssbohm, M
Migliori, GB
Schwoebel, V
Leitch, AG
Zellweger, JP
机构
[1] INT UNION AGAINST TB & LUNG DIS,PARIS,FRANCE
[2] PUBL HLTH LAB SERV,CTR COMMUNICABLE DIS SURVEILLANCE,LONDON NW9 5EQ,ENGLAND
[3] WHO,TB PROGRAMME,CH-1211 GENEVA,SWITZERLAND
[4] GERMAN CENT COMM AGAINST TB,DZK,OFF PUBL HLTH,WIESBADEN,GERMANY
[5] FDN SALVATORE MAUGERI,CLIN LAVORO & RIABILITAZ,CARE & RES INST,TRADATE,ITALY
[6] EUROPEAN CTR EPIDEMIOL MNITORING AIDS,ST MAURICE,FRANCE
[7] CHALMERS HOSP,ROYAL VICTORIA CHEST CLIN & TB SERV,EDINBURGH,MIDLOTHIAN,SCOTLAND
[8] SWISS ASSOC AGAINST TB,BERN,SWITZERLAND
关键词
Europe; surveillance; tuberculosis;
D O I
10.1183/09031936.96.09051097
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Consensus-based recommendations have been developed by a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) on uniform reporting of tuberculosis surveillance data in the countries of Europe. A uniform case definition and a minimum set of variables for reporting on each case have been agreed which, when collated on a national basis, will allow comparison of the epidemiology of tuberculosis in different European countries. The Working Group recommends that the case definition includes ''definite'' cases, where the diagnosis has been confirmed by culture (or supported by microscopy findings in countries where diagnostic culture facilities are not available), and ''other than definite cases'' based on a clinical diagnosis of tuberculosis combined with the intention to treat with a full course of antituberculosis therapy, Both ''definite'' and ''other than definite'' cases should be notified by physicians and, in addition, laboratories should be required to report ''definite'' cases. The minimum set of variables to be collected on each case of tuberculosis should include: date of starting treatment, place of residence, date of birth, gender, and country of origin, to characterize the patient, Recommended disease-specific variables include: site of disease, bacteriological status (microscopy and culture), and history of previous antituberculosis chemotherapy. The minimum set of variables should be collated on all patients and should be as complete as possible, Additional variables may be collected for individual, local or national purposes, but, in general, completeness of reporting on cases is likely to be better if the information requested is kept to a minimum. Timely reporting of cases is essential for appropriate public health action, Cases should be reported to the health authority at the local and/or regional level within 1 week of starting treatment, Individual-case based information should be reported to the national level by the local or regional level, Feedback to reporters is essential, At the national level, preliminary quarterly reports should be produced and final reports should be published annually.
引用
收藏
页码:1097 / 1104
页数:8
相关论文
共 50 条
  • [1] Surveillance of tuberculosis in Europe in 1996
    Schwoebel, V
    Antoine, D
    Veen, J
    TUBERCULOSIS IN HUMAN AND VETERINARY MEDICINE, 1999, : 57 - 62
  • [4] Surveillance, co-infection, resistance: tuberculosis in Europe
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2011, 11 (05): : 350 - 351
  • [5] Improving tuberculosis surveillance in Europe is key to controlling the disease
    D'Ambrosio, L.
    Centis, R.
    Spanevello, A.
    Migliori, G. B.
    EUROSURVEILLANCE, 2010, 15 (11): : 2 - 3
  • [6] Bovine tuberculosis in Europe from the perspective of an officially tuberculosis free country: Trade, surveillance and diagnostics
    Schiller, Irene
    RayWaters, W.
    Vordermeier, H. Martin
    Jemmi, Thomas
    Welsh, Michael
    Keck, Nicolas
    Whelan, Adam
    Gormley, Eamonn
    Boschiroli, Maria Laura
    Moyen, Jean Louis
    Vela, Carmen
    Cagiola, Monica
    Buddle, Bryce M.
    Palmer, Mitchell
    Thacker, Tyler
    Oesch, Bruno
    VETERINARY MICROBIOLOGY, 2011, 151 (1-2) : 153 - 159
  • [7] Social determinants and risk factors for tuberculosis in national surveillance systems in Europe
    de Colombani, P.
    Hovhannesyan, A.
    PUBLIC HEALTH ACTION, 2015, 5 (03): : 194 - 201
  • [8] Lessons learnt in Europe on tuberculosis surveillance, outbreaks and BCG vaccination in 2011
    van der Werf, Marieke J.
    Blasi, Francesco
    Giesecke, Johan
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) : 767 - 771
  • [9] Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007
    Devaux, I.
    Manissero, D.
    de la Hoz, K. Fernandez
    Kremer, K.
    van Soolingen, D.
    EUROSURVEILLANCE, 2010, 15 (11): : 15 - 20
  • [10] SURVEILLANCE OF TUBERCULOSIS
    STYBLO, K
    SOUTH AFRICAN MEDICAL JOURNAL, 1977, 51 (22): : 786 - 786